Pfizer's need for deal looms larger with earnings report

Written by Editor
Published in News Feeds

NEW YORK (Reuters) - Pfizer Inc's vulnerability to cheaper generics and its weak roster of experimental medicines will be on display Tuesday when the company reports quarterly earnings, reviving interest in its pursuit of AstraZeneca Plc or other deals to fortify its pipeline.

Read more http://uk.reuters.com/article/2014/07/28/uk-pfizer-strategy-idUKKBN0FX0A120140728?feedType=RSS&feedName=topNews

Action Sports

Pfizer's need for deal looms larger with earnings report

Teachers could be called on to estimate year 12 student grades – this is fairer than it sounds

Who's most affected on public transport in the time of coronavirus?

The swamp foxtail's origin is hidden in its DNA

'Climigration': when communities must move because of climate change

The National Sport Plan has ambitious ideas, but not enough specifics

Curious Kids: are humans going to evolve again?

Islamic art at the National Museum is spectacular, but misses opportunities to bridge a cultural gap

Politics podcast: Brian Howe on revisiting Henderson, poverty and basic income

Grattan on Friday: We are now a nation in self-isolation

Whiskey, Tango, Foxtrot: Afghanistan is FUBAR

Using 'she' and 'he' reinforces gender roles and discrimination of women